LOINC Code 75540-5: HAV RNA+Parvovirus B19 DNA NAA+probe Ql (P donor) [Interp]
75540-5 is a LOINC code used to identify HAV RNA+Parvovirus B19 DNA NAA+probe Ql (P donor) [Interp] in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Hepatitis A virus RNA+Parvovirus B19 DNA. It is commonly used with the system or sample type Plas^Donor.
What is this code?
LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Hepatitis A virus RNA+Parvovirus B19 DNA. It is commonly used with the system or sample type Plas^Donor.
When is it used?
- Used in lab systems, EHRs, and clinical data exchange.
- May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
- Status: ACTIVE
- Order vs observation: Both
- Method: Probe.amp.tar
What it does not mean
- The code identifies the observation or test, not the actual result.
Key facts
- Hepatitis A virus RNA+Parvovirus B19 DNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection
- Hepatitis A virus RNA+Parvovirus B19 DNA
- Simultaneously detects hepatitis A virus (HAV) RNA (genotypes 1-3) and parvovirus B19 (B19) DNA (genotypes 1-3) in human donor plasma, either from whole blood (recovered plasma) or collected by apheresis, prior to further manufacture. The aim is to reduce the B19 burden and remove HAV from plasma pools. This term represents the composite result of the individual HAV qualitative test and B19 quantitative test. If either result is reactive, the composite result is reactive; otherwise, it is nonreactive. Plasma may be tested as individual specimens or in pools. Not intended for use on samples of cord blood or as an aid in diagnosis. This term was created for, but is not limited in use to, the cobas TaqScreen DPX test kit.
- 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B19; B19 virus; B19V; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Donr; Fifth Disease; HAV; HAV RNA+B19V; Hep; Hep A; Hepatis; Hepatit; Hepatitis; Hepatitis A; Hepatitis type A; Hepatology; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Parvo; Parvo virus; Parvov; Parvovirus type b19; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification
Where you may see this code
You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.
Common synonyms
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.